Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis

NCT02201524 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

Enrollment

INDUSTRY

Sponsor class

Stopped Study terminated 26 June 2015 due to changes in the drug development portfolio. This study was not terminated for reasons of safety and/or efficacy

Conditions

Plaque Psoriasis

Interventions

DRUG: PF-04965842
DRUG: PF-04965842
DRUG: PF-04965842
OTHER: Placebo

Sponsor

Pfizer